Novo Nordisk’sNOVO.B-1.06%decrease; red down pointing triangle once-daily pill to treat type 2 diabetes ... the company’s blockbuster Ozempic and Wegovy diabetes and weight-loss drugs, and ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

Ozempic, Wegovy or Mounjaro: the battle of the weight-loss injections - As weight-loss injections emerge as key players in ...

The acquisition, announced in February, underscores Novo Nordisk’s push to boost output of its popular obesity drug Wegovy.

Although it is administered via injection, rather than in pill form, early results show a 200% higher weight loss reduction ...

Losing more than 8% of weight in less than a month. This is the promise of a pill under experimentation in the laboratories ...

also known as Mounjaro — that so far has shown even more weight loss than Wegovy. A pack of other companies are hot on both ...

once-daily obesity pill from Eccogene a year ago for up to $2 billion, it said it believed the treatment could cause fewer ...

Jefferies analyst Roger Song in an investor note said that Viking Therapeutics’ readout for its investigational therapy ...

Effectiveness and safety data from Viking’s study, released Sunday at an industry conference, show that an obesity pill could ...